Statewide Clinical Trials Network Of Texas Philadelphia, PA - 19118

Statewide Clinical Trials Network Of Texas is categorized under Medical Labs in Philadelphia, PA and active since 2010.

Statewide Clinical Trials Network Of Texas was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.

If you are seeking more information, feel free to contact Robert Young at the company’s single location by writing to 150 Lynnebrook Lane, Philadelphia, Pennsylvania PA 19118 or by phoning (215) 248-4727. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Statewide Clinical Trials Network Of Texas
Contact Person: Robert Young
Address: 150 Lynnebrook Lane, Philadelphia, Pennsylvania 19118
Phone Number: (215) 248-4727
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 621511
Share This Business:

Statewide Clinical Trials Network Of Texas was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Robert Young for inquiries that concern Statewide Clinical Trials Network Of Texas by calling the company number (215) 248-4727, as your correspondence is most welcome. Additionally, the physical location of the single location of Statewide Clinical Trials Network Of Texas can be found at the coordinates 40.083161,-75.209422 as well as the street address 150 Lynnebrook Lane in Philadelphia, Pennsylvania 19118.

For its online presence, you may visit Statewide Clinical Trials Network Of Texas’s website at and engage with its social media outlets through on Twitter and on Facebook.